Factors affecting improvement after intravenous administration of recombinant tissue plasminogen activator (rtPA) among patients with acute ischemic stroke: A historical cohort study

Factors affecting improvement after intravenous administration of recombinant tissue plasminogen activator (rtPA) among patients with acute ischemic stroke: A historical cohort study

Background: One of the most effective treatments for patients with acute ischemic stroke (AIS) is intravenous recombinant tissue plasminogen activator (rtPA) which can minimize mortality and morbidities. In this historical cohort study, we investigate the factors affecting clinical outcomes after IV...

Full description

Bibliographic Details
Main Authors: Seyed mohammad Masood Hojjati, Amir Hossein Hasanpour, Hoda Naghshineh, Ali Alizadeh khatir, Payam Saadat, Fatemeh Sahebian, Rahele Mehraeen, Hoda Shirafkan
Format: Article
Language:English
Published: Babol University of Medical Sciences 2024-02-01
Series:Caspian Journal of Internal Medicine
Subjects:
ischemic stroke
recombinant tissue plasminogen activator (rtpa)
thrombolytic therapy
prognosis.
Online Access:http://caspjim.com/article-1-3774-en.pdf

Internet

http://caspjim.com/article-1-3774-en.pdf

Similar Items